2017
DOI: 10.1186/s12974-017-0854-1
|View full text |Cite
|
Sign up to set email alerts
|

The involvement of mast cells in the irinotecan-induced enteric neurons loss and reactive gliosis

Abstract: BackgroundThe irinotecan (CPT-11) causes intestinal mucositis and diarrhea that may be related to changes in the enteric nervous system (ENS). In inflammatory condition, mast cells release a variety of pro-inflammatory mediators that can interact with the ENS cells. It has not been explored whether CPT-11 is able to alter the enteric glial and neuronal cell, and the role of mast cells in this effect. Therefore, this study was conducted to investigate the effect of CPT-11 on the enteric glial and neuronal cells… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
24
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
4
2
1

Relationship

1
6

Authors

Journals

citations
Cited by 32 publications
(28 citation statements)
references
References 51 publications
1
24
0
Order By: Relevance
“…Several in vitro and in vivo rodent models mimicking inflammation or infection revealed the activation and plasticity of EGCs. In a chemical‐induced mucositis model using the anticancer drug irinotecan (CPT‐11) a reactive gliosis accompanied by increased GFAP and S100b expression was shown in the small intestine whereas the number of the neuronal antigen Hu‐positive neurons is decreased (Nogueira et al, ).…”
Section: Introductionmentioning
confidence: 99%
“…Several in vitro and in vivo rodent models mimicking inflammation or infection revealed the activation and plasticity of EGCs. In a chemical‐induced mucositis model using the anticancer drug irinotecan (CPT‐11) a reactive gliosis accompanied by increased GFAP and S100b expression was shown in the small intestine whereas the number of the neuronal antigen Hu‐positive neurons is decreased (Nogueira et al, ).…”
Section: Introductionmentioning
confidence: 99%
“…An increase in GDNF and GFAP immunolabeling was observed in EGCs in inflamed colonic mucosa of patients with UC, CD, and Clostridioides difficile (C. difficile) infectious colitis [78]. In addition, S100B upregulation has also been identified in a variety of diseases, such as UC [42,81,82], celiac disease [83], and intestinal mucositis induced by antineoplastic drugs [84,85]. Increased expression of S100B was also found in the intestine of humans with C. difficile infection (CDI), in animal model of CDI, and in mouse ileal loop injected with C. difficile toxin A (TcdA) (unpublished data).…”
Section: Egcs In Inflammatory Bowel Diseases (Ibd)mentioning
confidence: 99%
“…As we will deepen later, EGCs can be stimulated by immune cells during intestinal inflammation. A recent study showed that mediators released by mast cells cause reactive gliosis and neuronal death together with the intestinal mucositis induced by irinotecan [85]. Figure 2 shows a schematic highlighting how EGCs are affected by and participates on intestinal inflammation.…”
Section: Inflammation By Other Causesmentioning
confidence: 99%
“…In addition, other sectons were stained with toluidine blue solution (1 g of toluidine blue dissolved in 70% ethanol), for evaluatin of mast cells (48). Mast cell granules stain purple in color due to the presence of heparin and histamine, therefore purple stain was recognized as a positive staining for mast cells.…”
Section: Histologymentioning
confidence: 99%
“…Intensely toluidine blue-stained granulated cells, as well as cells exhibiting different degrees of degranulation that paralleled lighter staining (degranulated), were observed. The results were expressed as the percentage of mast cells degranulated by total amount (48).…”
Section: Histologymentioning
confidence: 99%